Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel, Estrogenic Regulation of Cocaine Sensitization Teleconference.
Date: December 6, 2002.
Time: 12 p.m. to 1 p.m.
Agenda: to review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone conference call.)
Contact Person: Phillip F. Wiethorn, Scientific Review Administrator, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd, Suite 3208, MSC 9529, Bethesda, MD 20892-9529. (301) 496-5388.
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.
Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel, SPOTRIAS Special Emphasis Panel.
Date: December 16-17, 2002.
Time: 7:30 p.m. to 6 p.m.
Agenda: To review and evaluate grant applications.Start Printed Page 72425
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Katherine Woodbury, PhD, Scientific Review Administrator, Scientific Review Branch, NIDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd, Suite 3208, MSC 9549, Bethesda, MD 20892-95429. 301-496-9223.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853, clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS)Start Signature
Dated: November 26, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-30854 Filed 12-4-02; 8:45 am]
BILLING CODE 4140-01-M